441 related articles for article (PubMed ID: 35669067)
1. Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis.
Kanchanasurakit S; Kositamongkol C; Lanoi K; Nunta M; Saetuan T; Chaiyakunapruk N; Saokaew S; Phisalprapa P
Front Nutr; 2022; 9():880014. PubMed ID: 35669067
[TBL] [Abstract][Full Text] [Related]
2. Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Wang LL; Zhang PH; Yan HH
Front Nutr; 2023; 10():1014010. PubMed ID: 36866059
[TBL] [Abstract][Full Text] [Related]
3. Use of probiotics, prebiotics, and synbiotics in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Rong L; Ch'ng D; Jia P; Tsoi KKF; Wong SH; Sung JJY
J Gastroenterol Hepatol; 2023 Oct; 38(10):1682-1694. PubMed ID: 37409560
[TBL] [Abstract][Full Text] [Related]
4. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Loman BR; Hernández-Saavedra D; An R; Rector RS
Nutr Rev; 2018 Nov; 76(11):822-839. PubMed ID: 30113661
[TBL] [Abstract][Full Text] [Related]
5. The promising role of probiotics/prebiotics/synbiotics in energy metabolism biomarkers in patients with NAFLD: A systematic review and meta-analysis.
Li S; Liu J; Wang Z; Duan F; Jia Z; Chen X; Li S
Front Public Health; 2022; 10():862266. PubMed ID: 35958869
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.
Sharpton SR; Maraj B; Harding-Theobald E; Vittinghoff E; Terrault NA
Am J Clin Nutr; 2019 Jul; 110(1):139-149. PubMed ID: 31124558
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
Liu L; Li P; Liu Y; Zhang Y
Dig Dis Sci; 2019 Dec; 64(12):3402-3412. PubMed ID: 31203554
[TBL] [Abstract][Full Text] [Related]
8. The effects of supplementation of probiotics, prebiotics, or synbiotics on patients with non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials.
Xing W; Gao W; Lv X; Zhao Z; Mao G; Dong X; Zhang Z
Front Nutr; 2022; 9():1024678. PubMed ID: 36386939
[TBL] [Abstract][Full Text] [Related]
9. The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis.
Amini-Salehi E; Hassanipour S; Keivanlou MH; Shahdkar M; Orang Goorabzarmakhi M; Vakilpour A; Joukar F; Hashemi M; Sattari N; Javid M; Mansour-Ghanaei F
Nutr Rev; 2024 May; 82(6):815-830. PubMed ID: 37550264
[TBL] [Abstract][Full Text] [Related]
10. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
Ma YY; Li L; Yu CH; Shen Z; Chen LH; Li YM
World J Gastroenterol; 2013 Oct; 19(40):6911-8. PubMed ID: 24187469
[TBL] [Abstract][Full Text] [Related]
11. Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis.
Houttu V; Bouts J; Vali Y; Daams J; Grefhorst A; Nieuwdorp M; Holleboom AG
Front Endocrinol (Lausanne); 2022; 13():1032164. PubMed ID: 36407307
[TBL] [Abstract][Full Text] [Related]
12. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
[TBL] [Abstract][Full Text] [Related]
13. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis.
Khan MY; Mihali AB; Rawala MS; Aslam A; Siddiqui WJ
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):703-715. PubMed ID: 31009401
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Zhu Y; Xu J; Zhang D; Mu X; Shi Y; Chen S; Wu Z; Li S
Front Endocrinol (Lausanne); 2021; 12():769069. PubMed ID: 34956080
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD.
Hadi A; Mohammadi H; Miraghajani M; Ghaedi E
Crit Rev Food Sci Nutr; 2019; 59(15):2494-2505. PubMed ID: 29584449
[No Abstract] [Full Text] [Related]
16. Beneficial effects of probiotic and synbiotic supplementation on some cardiovascular risk factors among individuals with prediabetes and type 2 diabetes mellitus: A grade-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials.
Naseri K; Saadati S; Yari Z; Asbaghi O; Hezaveh ZS; Mafi D; Hoseinian P; Ashtary-Larky D; Hekmatdoost A; de Courten B
Pharmacol Res; 2022 Aug; 182():106288. PubMed ID: 35680009
[TBL] [Abstract][Full Text] [Related]
17. Probiotic and prebiotic interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis.
Jin H; Xu X; Pang B; Yang R; Sun H; Jiang C; Shao D; Shi J
Benef Microbes; 2021 Nov; 12(6):517-529. PubMed ID: 34511051
[TBL] [Abstract][Full Text] [Related]
18. Effects of probiotics, prebiotics, and synbiotics on polycystic ovary syndrome: a systematic review and meta-analysis.
Li Y; Tan Y; Xia G; Shuai J
Crit Rev Food Sci Nutr; 2023; 63(4):522-538. PubMed ID: 34287081
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: An umbrella study on meta-analyses.
Mahapatro A; Bawna F; Kumar V; Daryagasht AA; Gupta S; Raghuma N; Moghdam SS; Kolla A; Mahapatra SS; Sattari N; Amini-Salehi E; Nayak SS
Clin Nutr ESPEN; 2023 Oct; 57():475-486. PubMed ID: 37739694
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
Front Immunol; 2022; 13():949746. PubMed ID: 36159792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
